The invention provides doxorubicin and itraconazole common carrier nano-liposome which is mainly prepared from doxorubicin hydrochloride, itraconazole, phospholipids, other components, an ammonium sulfate solution and water for injection. The average grain diameter is 60-200 nm. The nano-liposome is prepared from, by mass, 1-40 parts of the doxorubicin hydrochloride, 1-20 parts of the itraconazole, 80-140 parts of the phospholipids and 20-100 parts of the other components; the other components are at least one of cholesterol, glycolipid and sitoesterol; the concentration of the ammonium sulfate solution is 100-400 mmol / L, and the water for injection is normal saline or glucose injection with the mass concentration of 5%. Medicine is endowed with a tumor tissue target ability through the lipidosome, tumor angiogenesis and tumor cell proliferation can be effectively restrained, and the toxic and side effects on normal tissue of the human body from the medicine are reduced.